49.19MMarket Cap-399P/E (TTM)
2.4150High2.1650Low273.76KVolume2.1700Open2.1500Pre Close624.38KTurnover1.76%Turnover RatioLossP/E (Static)20.41MShares9.000052wk High2.14P/B37.39MFloat Cap1.240052wk Low--Dividend TTM15.51MShs Float190.5000Historical High--Div YieldTTM11.63%Amplitude1.2400Historical Low2.2800Avg Price1Lot Size
Fortress Biotech Stock Forum
- SEC Filing
Fortress Biotech Inc: FDA Accepted Nda Filing for Dfd-29 to Treat Inflammatory Lesions & Erythema of Rosacea in Adults; Pdufa Goal Date of Nov 4, 2024
4 MINUTES AGO, 5:00 AM EST
VIA BUSINESSWIRE
• Half of the enrolled patients had stable disease for at least two months, two showed partial response and two experienced complete response
• Nature Medicine paper highlights delivery of CAR T cell therapy directly to the brain, a technique Ci...
$OptiNose(OPTN.US)$
when are the next date for $Checkpoint Therapeutics(CKPT.US)$ , $Fortress Biotech(FBIO.US)$ , and $Brainstorm Cell Therapeutics(BCLI.US)$ ?
all of these stocks currently not good fundamentally... some even minus PBV
No comment yet